145 related articles for article (PubMed ID: 8225826)
1. Relationship of blood groups and transitional cell carcinoma of the bladder.
Kirkali Z; Eryigit M
Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
[TBL] [Abstract][Full Text] [Related]
2. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
3. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
4. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.
Hilmy M; Bartlett JM; Underwood MA; McMillan DC
Br J Cancer; 2005 Feb; 92(4):625-7. PubMed ID: 15726119
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome.
Yossepowitch O; Dalbagni G
J Urol; 2002 Jul; 168(1):61-6. PubMed ID: 12050493
[TBL] [Abstract][Full Text] [Related]
7. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma].
Radulović P; Pavić I; Marusić Z; Perić-Balja M; Znaor A; Kraus O; Kruslin B
Lijec Vjesn; 2008; 130(1-2):1-3. PubMed ID: 18589634
[TBL] [Abstract][Full Text] [Related]
10. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
Malmström PU; Busch C; Norlen BJ
Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
[No Abstract] [Full Text] [Related]
11. [Clinical prognostic factors in superficial cancer of the urinary bladder].
Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
[TBL] [Abstract][Full Text] [Related]
12. Influence of blood group type on prognosis of transitional cell carcinoma of the urinary bladder.
Malmström U; Busch C; Norlen BJ; Andersson B
Eur Urol; 1990; 18(2):97-100. PubMed ID: 2226592
[TBL] [Abstract][Full Text] [Related]
13. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma.
Kamel MH; Daly PJ; Khan MF; Kay EW; O'Kelly P; Hickey DP
Eur J Surg Oncol; 2006 Dec; 32(10):1139-43. PubMed ID: 16784833
[TBL] [Abstract][Full Text] [Related]
14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
Lee SE; Park MS
Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating transitional cell carcinoma of the bladder--treatment results.
Heyns CF; Aucamp JW
S Afr J Surg; 1996 May; 34(2):82-6, 91-3; discussion 93-4. PubMed ID: 8764954
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of pure epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci].
Budía Alba A; Queipo Zaragozá JA; Pérez Ebrí ML; Fuster Escrivá A; Vera Donoso DC; Vera Sempere FJ; Jiménez Cruz JF
Actas Urol Esp; 1999 Feb; 23(2):111-8. PubMed ID: 10327674
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
Daneshmand S; Stein JP; Lesser T; Quek ML; Nichols PW; Miranda G; Cai J; Groshen S; Skinner EC; Skinner DG
J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
